CMS Open Payments · Program Year 2024
Onkos Surgical, Inc.
Onkos Surgical, Inc. reported $402,286.63 across General Payments, Research, and Ownership to 461 physicians and teaching hospitals across 461 transactions.
- $402.3K
- All-tracks total
- 461
- Transactions
- 461
- Recipients
- +$119.0K
- General Payments vs PY2023
Onkos Surgical, Inc. reported $402,286.63 across all CMS Open Payments tracks (General + Research + Ownership) to 461 physicians and teaching hospitals in Program Year 2024 - ranking #820 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $402,286.63, averaging $872.64 per recipient.
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer onkos-surgical-inc Onkos Surgical, Inc.
$402.3K · #820/1,925 · 0.0% industry · PY2024
- TOT $402.3K
- RANK #820
- SHARE 0.0%
- TXN 461
- RCP 461
- CAT 4
- GEN $402.3K
- ΔGEN +$119.0K
- TOP1 14.0%
- PY 2024
Volume peers
Nearest volume peer: Geistlich Pharma, North America, Inc. ($401.7K)
Onkos Surgical, Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Onkos Surgical, Inc.'s CMS-reported General Payments increased by $119.0K (+42.0%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: ONKOS SURGICAL, INC.PY2023: ONKOS SURGICAL, INC.PY2024: Onkos Surgical, Inc.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $283,315.30
- PY2024
- $402,286.63
What the Data Shows for Onkos Surgical, Inc.
Averaging $872.64 per transaction and $872.64 per recipient, Onkos Surgical, Inc.'s Program Year 2024 total comes to $402,286.63 across 461 transactions and 461 physicians and teaching hospitals. In the CMS Open Payments database that is good for rank #820 of 1,925 companies, a comparatively small 0.0% slice of all industry payments reported nationwide for the year.
Of the 4 general-payment categories charted below, "Royalty or License" is the largest at $221.0K across 16 transactions, 54.9% of this company's General Payments (see our methodology for how research and ownership payments are reported separately).
General Payment Breakdown by Type
Onkos Surgical, Inc. made 4 types of general payments. "Royalty or License" is the largest category at $221.0K, 54.9% of General Payments.
Onkos Surgical, Inc. reports 4 general-payment categories - the top three are Royalty or License (54.9%), Consulting Fee (35.4%), and Food and Beverage (6.9%). The remaining 1 category make up 2.7% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.
How Onkos Surgical, Inc. divides its payments
General-payment categories, ordered by reported total
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Royalty or License | $221.0K | 16 | 54.9% |
| Consulting Fee | $142.5K | 46 | 35.4% |
| Food and Beverage | $27.8K | 355 | 6.9% |
| Travel and Lodging | $11.0K | 44 | 2.7% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $260,671.24 (64.8%) of $402,286.63 in this company's General Payments records across 253 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Onkos Surgical, Inc.
The five named recipients with the highest reported General Payments from this company
- 1
Jorge Casas
$56,328.51 across 11 reported transactions
- 2
Kevin Andrew Raskin
$55,988.80 across 5 reported transactions
- 3
Matthew J Seidel
$55,225.92 across 5 reported transactions
- 4
Judd Edward Cummings
$55,225.92 across 5 reported transactions
- 5
Steven Gitelis
$37,902.09 across 6 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Onkos Surgical, Inc.'s, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Onkos Surgical, Inc..
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Onkos Surgical, Inc..
Showing 6 of 1,924 companies with CMS-reported payment data.
Mizuho America, Inc.
Agfa HealthCare Corporation
Nova Eye, Inc.
Osseus Fusion Systems, LLC
Amarin Pharma Inc.
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.